Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04450342 · ClinicalTrials.gov registry record · NA
REGENETEN™ Bioinductive Implant System in Full-thickness Tears
A NA study, sponsored by Smith & Nephew.
- Terminated
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT04450342 is a NA study that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 119 participants.
The verdict
NCT04450342, a NA study, was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
The study is designed to assess the safety and efficacy of Arthroscopic rotator cuff repair (ARCR) augmented with REGENETEN in subjects requiring full-thickness rotator cuff tear repair or revision repair versus Arthroscopic rotator cuff repair alone.
Interventions
- PROCEDURE Arthroscopic rotator cuff repair
- DEVICE Arthroscopic rotator cuff repair with REGENETEN™ Bioinductive Implant augmentation
- DEVICE Arthroscopic rotator cuff repair for revision surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2020-12-07 |
| Est. Completion | 2023-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04450342
The ClinicalTrials.gov registry entry for NCT04450342 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Arthroscopic rotator cuff repair is the first listed.
NCT04450342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04450342 about?
NCT04450342 is a clinical study titled "REGENETEN™ Bioinductive Implant System in Full-thickness Tears". The study is designed to assess the safety and efficacy of Arthroscopic rotator cuff repair (ARCR) augmented with REGENETEN in subjects requiring full-thickness rotator cuff tear repair or revision repair versus Arthroscopic rotator cuff repair alone.
What is the current status of trial NCT04450342?
This trial is currently terminated. It is a NA study. The enrollment target is 119 participants. The study started on 2020-12-07. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT04450342?
The interventions under investigation include: Arthroscopic rotator cuff repair (PROCEDURE), Arthroscopic rotator cuff repair with REGENETEN™ Bioinductive Implant augmentation (DEVICE), Arthroscopic rotator cuff repair for revision surgery (DEVICE).
Who is sponsoring clinical trial NCT04450342?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.